CM
CM Management Portfolio holdings
AUM
$110M
This Quarter Return
-2.07%
1 Year Return
+9.76%
3 Year Return
+99.54%
5 Year Return
–
10 Year Return
–
AUM
$89.6M
AUM Growth
+$89.6M
(-4.7%)
Cap. Flow
-$1.02M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
36.69%
Holding
74
New
5
Increased
31
Reduced
13
Closed
3
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$1.05M |
| 2 |
B
Barrick Mining Corporation
B
|
$853K |
| 3 |
Ark Restaurants
ARKR
|
$799K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$785K |
| 5 |
FedEx
FDX
|
$742K |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$2.42M |
| 2 |
PTC Therapeutics
PTCT
|
$1.8M |
| 3 |
Cadence Bank
CADE
|
$1.64M |
| 4 |
Talos Energy
TALO
|
$1.25M |
| 5 |
Energy Transfer Partners
ET
|
$1.1M |
Sector Composition
| 1 | Healthcare | 37.28% |
| 2 | Financials | 10.8% |
| 3 | Energy | 9.75% |
| 4 | Industrials | 9.02% |
| 5 | Technology | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Citigroup
C
$175B
| $625K | 0.7% |
15,000
-10,000
| -40% | -$417K |
|
52
Fidelity National Information Services
FIS
$35.6B
| $567K | 0.63% |
+7,500
| New | +$567K |
|
53
Elicio Therapeutics
ELTX
$169M
| $552K | 0.62% |
60,000
+7,500
| +14% | +$69K |
|
54
Plains GP Holdings
PAGP
$3.71B
| $546K | 0.61% |
50,000
-100,000
| -67% | -$1.09M |
|
|
SVC
55
Service Properties Trust
SVC
$456M
| $519K | 0.58% |
100,000
| – | – |
|
56
Smith Micro Software
SMSI
$15.2M
| $486K | 0.54% |
26,875
+5,000
| +23% | +$90.4K |
|
|
AE
57
DELISTED
Adams Resources & Energy Inc.
AE
| $447K | 0.5% |
15,000
-13,950
| -48% | -$416K |
|
58
inTEST
INTT
$90.7M
| $420K | 0.47% |
55,000
| – | – |
|
59
Gain Therapeutics
GANX
$69M
| $408K | 0.46% |
125,000
| – | – |
|
|
BCEL
60
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $391K | 0.44% |
249,282
+24,282
| +11% | +$38.1K |
|
61
Republic Bancorp
RBCAA
$1.48B
| $383K | 0.43% |
10,000
-15,077
| -60% | -$577K |
|
|
CBAY
62
DELISTED
Cymabay Therapeutics
CBAY
| $350K | 0.39% |
100,000
-110,000
| -52% | -$385K |
|
|
SPPI
63
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $344K | 0.38% |
800,000
+200,000
| +33% | +$86K |
|
64
Femasys
FEMY
$12M
| $339K | 0.38% |
300,000
| – | – |
|
65
Amneal Pharmaceuticals
AMRX
$3B
| $303K | 0.34% |
150,000
+50,000
| +50% | +$101K |
|
66
Lantern Pharma
LTRN
$46.3M
| $239K | 0.27% |
50,000
+4,900
| +11% | +$23.4K |
|
67
Pan American Silver
PAAS
$12.3B
| $238K | 0.27% |
15,000
+5,000
| +50% | +$79.3K |
|
68
Edesa Biotech
EDSA
$17.2M
| $230K | 0.26% |
+35,714
| New | +$230K |
|
|
MCLD
69
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
| $223K | 0.25% |
142,764
-52,402
| -27% | -$81.9K |
|
|
NBSE
70
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $178K | 0.2% |
22,500
+4,000
| +22% | +$31.6K |
|
71
Nektar Therapeutics
NKTR
$543M
| $160K | 0.18% |
3,333
-5,000
| -60% | -$240K |
|
|
72
Cadence Bank
CADE
$6.97B
| – | – |
-70,000
| Closed | -$1.64M |
|
73
Compass Therapeutics
CMPX
$466M
| – | – |
-30,000
| Closed | -$80K |
|
|
74
PTC Therapeutics
PTCT
$4.41B
| – | – |
-45,000
| Closed | -$1.8M |
|